World vs Zambia: Access to anti-retroviral drugs, female
World
83.0%
in 2024
Zambia
96.0%
in 2024
World rank
15th
Zambia rank
14th
Access to anti-retroviral drugs, female over time
- World
- Zambia
How they compare
Zambia currently reports 96.0% against 83.0% in World, a difference of 13.0%.
That makes Zambia's figure about 1.2 times World's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was World ahead.
World ranks 15th and Zambia ranks 14th of 19 groups.
Zambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | World | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.5% | 10.5% | 4.0% | Zambia |
| 2010s | 49.3% | 60.0% | 10.7% | Zambia |
| 2020s | 78.2% | 92.4% | 14.2% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, World or Zambia?
- Zambia, at 96.0% against 83.0% in World as of 2024.
- What is the difference in access to anti-retroviral drugs, female between World and Zambia?
- 13.0%, with Zambia ahead.
- How many years of comparable data are there for World and Zambia?
- 25 years are reported by both, from 2000 to 2024.
- How do World and Zambia rank globally for access to anti-retroviral drugs, female?
- World ranks 15th and Zambia ranks 14th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.